Just reading about the FDA’s response to Mesoblast and making Mesoblast go back retrial at the final hurdle. mSB share price has been hammered as a result. I don’t think it’s a given that the FDA will allow one trial for Invex either. Let’s see. Hope I’m wrong.
I do agree about the comment re that they are stretched. The team is scattered all over the world and it’s small.
has anyone contacted the company to get an update? I haven’t but wondering if anyone has some idea of what is going on over there?
Just reading about the FDA’s response to Mesoblast and making...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
